Incidence of admissions due to pneumonia in children under 24 months old before and after the introduction of the 10-valent pneumococcal conjugate vaccine into the National Immunization Program of Chile;Incidencia de egresos por neumonía en ni˜nos menores de 24 meses antes y después de la implementación de la vacuna conjugada antineumocócica 10-valente en el Programa Nacional de Inmunizaciones de Chile

Revista Chilena de Pediatria

Volumn 86, Issue 3, 2015, Pages 168-172

  Fernández V , José Pablo ^a   Goecke H , Carola ^a   von Borries, Cecilia ^a   Tapia R , Natalia ^a   Santolaya de P , María Elena ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Incidence; Pneumonia; Streptococcus pneumoniae; Vaccine

Indexed keywords

PNEUMOCOCCUS VACCINE; 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE;

ARTICLE; BACTERIAL PNEUMONIA; CHILE; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFANT; MORBIDITY; PNEUMONIA; PREVENTIVE HEALTH SERVICE; VACCINATION; FEMALE; HOSPITALIZATION; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCOCCAL; RETROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIAE;

CHILE; FEMALE; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; MALE; PNEUMOCOCCAL VACCINES; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCOCCAL; RETROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 84941786370     PISSN: 03704106     EISSN: 07176228     Source Type: Journal    
DOI: 10.1016/j.rchipe.2015.04.026     Document Type: Article

References (16)

1. Consenso Neumonía adquirida en la comunidad. Rev Chil Enf Respir. 1999;15:107-9
2. Heiskanen-Kosma T, Korppi M, Jokinen C, Kurki S, Heiskanen L, Juvonen H, Kallinen S, Stén M, Tarkiainen A, Rönnberg PR, Kleemola M, Mäkelä PH, Leinonen M. Etiology of childhood pneumonia: Results of a prospective, population based study. Pediatr Infect Dis J. 1998;17:986-91
3. Juvén T, Mertsola J, Waris M, Leinonen M, Meurman O, Roivainen M, Eskola J, Saikku P, Ruuskanen O. Etiology of communityacquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J. 2000;19:293-8
4. Ferrari AM, Pirez C, Martínez A, Algorta G, Chamorro F, Guala MJ, Zabala C, Giachetto G, Montano A. Etiología de la neumonía bacteriana adquirida en la comunidad en ni˜nos hospitalizados: Uruguay 1998-2004. Rev Chil Infect. 2007;24:40-7
5. Vesga J, Cortés J. Desarrollo, impacto y eficacia de la vacuna conjugada contra Streptoccocus pneumoniae en America Latina. Rev Chil Ped. 2006;77:341-9
6. Comité Asesor de Vacunas y Estrategias de Inmunización. Ministerio de Salud de Chile. Fundamentos de la recomendación del uso de la vacuna neumocócica. 2010
7. World Health Organization. Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. 22. Wkly Epidemiol Rec. 2007;82:93-104
8. Madhi SA, Kuwanda L, Cutland P, Klugman KP. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin Infect Dis. 2005;40:1511-8
9. Black S, Shinefield H, Ling S, Hansen J, Fireman B, Spring D, Noyes J, Lewis E, Ray P, Lee J, Hackell J. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Ped Infect Dis J. 2002;21:810-5
10. Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, Oluwalana C, Vaughan A, Obaro SK, Leach A, McAdam KP, Biney E, Saaka M, Onwuchekwa U, Yallop F, Pierce NF, Greenwood BM, Adegbola RA, Gambian Pneumococcal Vaccine Trial Group. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: Randomised, double-blind, placebo-controlled trial. Lancet. 2005;365:1139-46
11. Hansen J, Black S, Shinefield H, Cherian T, Benson J, Fireman B, Lewis E, Ray P, Lee J. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: Updated analysis using World Health Organization standardized interpretation of chest radiographs. Ped Infect Dis J. 2006;25:779-81
12. Klugman K, Madhi S, Huebner R, Kohberger R, Mbelle N, Pierce N, for the Vaccine Trialist Group. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med. 2003;349:1341-8
13. Lucero M, Nohynek H, Williams G, Tallo V, Simões EA, Lupisan S, Sanvictores D, Forsyth S, Puumalainen T, Ugpo J, Lechago M, de Campo M, Abucejo-Ladesma E, Sombrero L, Nissinen A, Soininen A, Ruutu P, Riley I, Mäkelä HP. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than two years of age in the Philippines: a randomized, double-blind, placebo- controlled trial. Ped Infect Dis J. 2009;28:455-62
14. Instituto de Salud Pública. Vigilancia de enfermedad invasora Streptococcus pneumoniae. Chile, 2007-2013 [acceso 2 Feb 2014]. Disponible en: http://www.ispch.cl/
15. Rosenblut M, Maul X, Rosenblut A. Incidencia de otitis media aguda en ni˜nos del sector Sur Oriente de Santiago antes y después de la implementación de vacuna antineumocócica 10 valente en el programa nacional de inmunizaciones. Rev Otorrinolaringol Cir Cabeza Cuello. 2013;73:238-42
16. Tregnaghi MW, Sáez-Llorens X, López P, Abate H, Smith E, Pósleman A, Calvo A, Wong D, Cortes-Barbosa C, Ceballos A, Tregnaghi M, Sierra A, Rodriguez M, On behalf of the COMPAS Group. Efficacy of pneumococcal non typable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial. PLoS Medicine. 2014;11:1-18.